tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Irina Rivkind Koffler - 14 which are a Buy (48.28%), 9 which are a Hold (31.03%), 6 which are a Sell (20.69%)
Analyst Irina Rivkind Koffler works at LIFESCI and is covering the Healthcare sector with 514 price targets and ratings displayed on 3 stocks. Previously, Irina Rivkind Koffler worked at MIZUHO, CANTOR FITZGERALD.
Irina Rivkind Koffler's average stock forecast success ratio is 65.12% with an average time for price targets to be met of 211.88 days.
Most recent stock forecast was given on MNK, at 06-Aug-2019.
Analyst best performing recommendations are on DRRX (DURECT).
The best stock recommendation documented was for EGRX (EAGLE PHARMACEUTICALS) at 1/9/2017. The price target of $64 was fulfilled within 2 days with a profit of $4.1 (6.02%) receiving and performance score of 30.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
27
$24.51 (984.34%)
32
3 months 25 days ago
0/2 (0%)
$25.57 (661.71%)
Buy
3 months 25 days ago
0/2 (0%)
$26.55 (102.36%)
Buy
3 months 25 days ago
0/1 (0%)
$42.3 (238.98%)
Buy
6
$5.34 (809.09%)
60
11 months 28 days ago
1/4 (25%)
$36.17 (257.00%)
34
Buy
80
$79.34 (12021.21%)
2 years 7 months ago
0/3 (0%)
$55.68 (315.59%)
What Year was the first public recommendation made by Irina Rivkind Koffler?
